| BUSINESSWEEK ONLINE : APRIL 10, 2000 ISSUE | ||||||||
| ||||||||
 | ||||||||
| SCIENCE & TECHNOLOGY
Out in Front A handful of biotech companies is developing the technologies necessary to
analyze proteins on the broadest scale. Here are some early leaders in this new
field:
COMPANY LOCATION TECHNOLOGY COLLABORATIONS
CELERA GENOMICS Rockville, Md. Global protein N/A
identification
CIPHERGEN BIOSYSTEMS Palo Alto, Calif. Protein chips National Cancer
Institute
HYBRIGENICS Paris Protein-protein Small Molecule
interactions Therapeutics
LARGE SCALE BIOLOGY Rockville, Md. Global protein AstraZeneca,
identification Bristol-Myers
Squibb
MYRIAD GENETICS Salt Lake City Protein-protein Bayer, Monsanto,
interactions Schering
OXFORD GLYCOSCIENCES Oxford, England Global protein Pfizer, Bayer,
identification Incyte Pharma-
ceuticals
PROTEOME SYSTEMS Sydney Global protein Dow AgroSciences
identification
_ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ BACK TO TOP |
|  |
 | |
RELATED ITEMS Beyond the Genome: Biotech's Next Holy Grail TABLE: Proteomics 101 TABLE: Out in Front First Silicon. Then DNA. And Soon, Protein Chips Tobacco Turns Over a New Leaf INTERACT E-Mail to Business Week Online | |||
|
Copyright 2000-2008, by The McGraw-Hill Companies Inc. All rights reserved.
Terms of Use Privacy Notice  |